Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Daclizumab for Active, Non-infectious, Sight-threatening Uveitis: A Phase II Pilot Study

NCT00070759 is registered in ClinicalTrials.gov with National Eye Institute (NEI) as lead sponsor.

NCT NCT00070759
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00070759 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Daclizumab for Active, Non-infectious, Sight-threatening Uveitis: A Phase II Pilot Study
Lead sponsor
National Eye Institute (NEI)
Phase
Phase 2
Overall status
Completed
Start date
October 6, 2003
Completion date
October 2, 2006
Enrollment
6
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

uveitis